[Cholecystokinin and its antagonists: effects on digestive motility].
Bruley des Varannes
S
S
Groupe Fonctions Digestives et Nutrition, Unité d'Explorations Fonctionnelles Digestives, CHU G-et-R-Laennec, Nantes.
Cloarec
D
D
Dubois
A
A
Galmiche
J P
JP
D001570:Benzodiazepinones / Q000494:pharmacology*; D001921:Brain / Q000502:physiology; D002766:Cholecystokinin / Q000037:antagonists & inhibitors / Q000502:physiology*; D020109:Devazepide; D004947:Esophagus / Q000187:drug effects / Q000502:physiology; D005704:Gallbladder / Q000187:drug effects / Q000502:physiology; D005746:Gastric Emptying / Q000187:drug effects; D005769:Gastrointestinal Motility / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D011377:Proglumide / Q000031:analogs & derivatives / Q000494:pharmacology*; D011949:Receptors, Cholecystokinin / Q000187:drug effects / Q000502:physiology
D001570:Benzodiazepinones; D011949:Receptors, Cholecystokinin; C053737:loxiglumide; D002766:Cholecystokinin; D011377:Proglumide; D020109:Devazepide; C046367:asperlicin
Cholécystokinine et ses antagonistes: effets sur la motricité digestive.